Pharmaceuticals News and Research

RSS

Tips on how to prevent unnecessary medication/supplement mishaps

Navigating the supplement and medication maze can get confusing especially when you have multiple prescriptions. It is important to organize yourself with your medications and supplements to prevent unnecessary mishaps.

7 Oct 2011

Scientists discover rare genetic alteration responsible for hypoglycaemia

Cambridge scientists have identified the cause of a rare, life-threatening form of hypoglycaemia. Their findings, which have the potential to lead to pharmaceutical treatments for the disorder, were published today, 07 October, in the journal Science.

7 Oct 2011

Researchers gain insight on how roundworm's brain operates as it moves

Using new optical equipment, a team of 11 researchers put roundworms into a world of virtual reality, monitored both their behavior and brain activity and gained unexpected information on how the organism's brain operates as it moves.

4 Oct 2011

Quick injection of cortisone can prevent PTSD

As soldiers return home from tours in Afghanistan and Iraq, America must cope with the toll that war takes on mental health. But the treatment of Post Traumatic Stress Disorder (PTSD) is becoming increasingly expensive, and promises to escalate as yet another generation of veterans tries to heal its psychological wounds.

4 Oct 2011

Scientists develop first polymeric material that is sensitive to very low levels of NIR irradiation

Scientists at the University of California, San Diego have developed what they believe to be the first polymeric material that is sensitive to biologically benign levels of near infrared (NIR) irradiation, enabling the material to disassemble in a highly controlled fashion.

4 Oct 2011

TriLogic, Mission Pharmacal partner to develop new drug delivery system

Mission Pharmacal Company announced today that it is developing a new drug delivery system utilizing technology developed by TriLogic Pharma. The delivery system will be based upon TriLogic's proprietary drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development.

4 Oct 2011

Santaris Pharma to report new clinical data from miravirsen Phase 2a study on HCV

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA and mRNA-targeted therapies, today announced the Company will report new clinical data results from the miravirsen Phase 2a proof-of-concept study to treat patients infected with the Hepatitis C virus (HCV) in a late-breaking oral presentation session at the American Association for the Study of Liver Diseases (AASLD) 2011 annual meeting.

4 Oct 2011

Adaptimmune announces new board appointments as clinical programmes get underway

Adaptimmune, the T cell therapy company pioneering enhanced T cell receptor-driven T cells for the treatment of cancer and infectious disease, announces two new Board appointments with immediate effect. Dr Jonathan Knowles joins the Board as a non-executive director and Dr Helen Tayton-Martin, Adaptimmune’s Chief Operating Officer, becomes an executive director.

3 Oct 2011

EntreMed announces data from ENMD-2076 Phase 2 study in platinum-resistant ovarian cancer

EntreMed, Inc., a clinical stage pharmaceutical company developing therapeutics for the treatment of cancer today announced the final data for the primary endpoint of progression free survival rate at 6 months for its Phase 2 study with ENMD-2076 in platinum-resistant ovarian cancer patients.

3 Oct 2011

Dosing commences in Auxilium's XIAFLEX phase IIIb trial for Dupuytren's contracture

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that the first patients have been dosed in the Company's phase IIIb trial of XIAFLEX® for the treatment of adult Dupuytren's contracture patients with multiple palpable cords.

3 Oct 2011

Florida AHCA renews Medicaid Management Information System service agreement with HP

HP Enterprise Services today announced the Florida Agency for Health Care Administration (AHCA) has signed a renewal service agreement to manage the state's Medicaid Management Information System.

3 Oct 2011

GeoVax completes enrollment for HIV/AIDS vaccine Phase 2a clinical trial

GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today the completion of enrollment for a Phase 2a clinical trial testing its HIV/AIDS vaccine.

3 Oct 2011

Marken introduces new global brand and advertising campaign

Marken, a global leader in supporting clinical research logistics, announced the launch of a new global brand and advertising campaign to reflect the unique position that it holds in the pharmaceutical industry.

3 Oct 2011

CSL pays heed to FDA observations on faulty manufacturing processes

Australia’s biggest pharmaceutical company CSL has taken steps to address most manufacturing flaws highlighted by the US Food and Drug Administration (FDA) and promised that the remaining concerns are being resolved.

2 Oct 2011

AHF protests J&J over AIDS drug prices

A group of committed AIDS activists and advocates are expected to participate in a protest and "die-in" hosted by AIDS Healthcare Foundation (AHF) Friday, September 30th at 12:30 pm near the New Brunswick headquarters of Johnson & Johnson to protest the company's pricing of its HIV/AIDS medications.

1 Oct 2011

Regulatory, commercial considerations are the primary drivers for biosimilar development

Regulatory and commercial considerations are the primary drivers for successful biosimilar clinical development, according to a new report from Quintiles, titled An Integrated Approach to Biosimilar Development & Commercialization. In addition, the report states that successful biosimilar companies will be those who collapse their clinical, commercial, and regulatory thinking into a streamlined cohesive function as they proceed with developing biosimilars.

1 Oct 2011

Planned clinical trial of Adeona's zinc-based therapy for ALS patients to be featured at ALS Summit

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that its planned clinical trial of the Company's proprietary zinc-based therapy for patients suffering from amyotrophic lateral sclerosis, also known as Lou Gehrig's Disease, will be featured during the Hot Topics session at the 2011 California ALS Research Summit on Saturday, October 1, 2011.

1 Oct 2011

Safeway introduces chain-wide breast cancer fundraising initiative

Safeway Inc. today launched its annual October chain-wide breast cancer fundraising initiative. The company has raised more than $94 million for the cause since 2001.

1 Oct 2011

Tips for seniors to avoid serious complications from prescription meds

For seniors, October is a month in which medications - particularly prescription meds - will likely be on their minds. Not only is October national "Talk About Prescriptions Month," but Oct. 15 marks the start of Medicare's Annual Election Period during which beneficiaries can disenroll from, switch or enroll into a Medicare Advantage or Part D plan.

1 Oct 2011

CSRO survey explores impact of health insurance barriers

The Coalition of State Rheumatology Organizations today released the findings of a nationwide survey that explored the impact of health insurance barriers such as prior authorization and step therapy on the ability of rheumatologists to provide effective care to patients.

1 Oct 2011

Pharmaceuticals News and Research

Tips on how to prevent unnecessary medication/supplement mishaps

Scientists discover rare genetic alteration responsible for hypoglycaemia

Researchers gain insight on how roundworm's brain operates as it moves

Quick injection of cortisone can prevent PTSD

Scientists develop first polymeric material that is sensitive to very low levels of NIR irradiation

TriLogic, Mission Pharmacal partner to develop new drug delivery system

Santaris Pharma to report new clinical data from miravirsen Phase 2a study on HCV

Adaptimmune announces new board appointments as clinical programmes get underway

EntreMed announces data from ENMD-2076 Phase 2 study in platinum-resistant ovarian cancer

Dosing commences in Auxilium's XIAFLEX phase IIIb trial for Dupuytren's contracture

Florida AHCA renews Medicaid Management Information System service agreement with HP

GeoVax completes enrollment for HIV/AIDS vaccine Phase 2a clinical trial

Marken introduces new global brand and advertising campaign

CSL pays heed to FDA observations on faulty manufacturing processes

AHF protests J&J over AIDS drug prices

Regulatory, commercial considerations are the primary drivers for biosimilar development

Planned clinical trial of Adeona's zinc-based therapy for ALS patients to be featured at ALS Summit

Safeway introduces chain-wide breast cancer fundraising initiative

Tips for seniors to avoid serious complications from prescription meds

CSRO survey explores impact of health insurance barriers

Event guide: World ADC San Diego eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence